Syndax Pharmaceuticals Inc (SNDX)
15.60
-0.35
(-2.19%)
USD |
NASDAQ |
Nov 21, 16:00
15.59
-0.01
(-0.06%)
After-Hours: 20:00
Syndax Pharmaceuticals Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.0558 |
March 31, 2022 | 0.0535 |
December 31, 2021 | 0.0487 |
September 30, 2021 | 0.1029 |
June 30, 2021 | 0.0949 |
March 31, 2021 | 0.0887 |
December 31, 2020 | 0.0798 |
September 30, 2020 | 0.1516 |
June 30, 2020 | 0.1348 |
March 31, 2020 | 0.3699 |
Date | Value |
---|---|
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.1155 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.3699
Maximum
Mar 2020
0.059
Average
0.0244
Median
Debt to Equity Ratio Benchmarks
Vertex Pharmaceuticals Inc | 0.00 |
Moderna Inc | 0.00 |
NovaBay Pharmaceuticals Inc | 0.0476 |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 425.81M |
Total Liabilities (Quarterly) | 59.38M |
Shareholders Equity (Quarterly) | 366.43M |
Current Ratio | 6.986 |